Gearing Up for the 2nd Annual Pharma Impurities Conclave 2024- September 12th -13th
Unveiling innovations & anticipating breakthroughs
The challenge of managing and mitigating impurities in drug products remains a critical focus with recent advancements in pharma. Impurities can pose serious health risks to patients and the presence of impurities can affect the safety, efficacy, stability, and the quality of the drugs. To understand the challenges faced by scientists and analytical R&D experts to rid of residual solvents, degradants, or process related impurities, this conclave facilitates knowledge sharing, best practices dissemination, and regulatory updates to ensure practical understanding of those aspects and encourages the highest standards of product quality and patient safety. Ultimately, the 2nd Annual Pharma Impurity Conclave 2024 by Eminence Business Media, scheduled for September 12th – 13th at Hyderabad, serves as a critical platform for the industry professionals to address to those pressing needs for stringent impurity control in drug manufacturing.
Addressing Key Challenges in Pharmaceutical Impurities
Pharmaceutical impurities, whether they arise during the manufacturing process or through degradation over time, can pose significant risks to patient safety. The regulatory landscape governing these impurities is complex and continually evolving. 2nd Annual Pharma Impurities Conclave 2024 aims to provide attendees with the latest insights and practical strategies to navigate these challenges effectively.
A Stellar Line-Up of Expert Speakers
The event will feature a distinguished line-up of speakers from regulatory bodies and leading pharma companies. By bringing together scientists, regulatory experts, and industry leaders, the conclave is to foster collaboration and innovation in impurity analysis, detection, and control strategies.
Key Topics and Sessions
Participants can look forward to a comprehensive agenda that covers a wide range of topics related to pharmaceutical impurities:
Regulatory Updates: Detailed discussions on the latest guidelines from MHRA, FDA, EMA, and ICH, with a focus on permissible impurity levels and compliance requirements.
Analytical Techniques: Sessions on cutting-edge analytical methods for detecting and quantifying impurities, including advancements in mass spectrometry and chromatography.
Risk Assessment and Management: Expert-led discussions on risk assessment frameworks and best practices for managing impurities to ensure patient safety.
Case Studies: Real-world examples of impurity identification, mitigation strategies, and successful regulatory submissions.
Genotoxic Impurities: Special focus on the detection, evaluation, and control of genotoxic impurities, which can pose significant risks even at low levels.Networking and Collaboration Opportunities
The conclave will also provide ample opportunities for networking and collaboration. Attendees can engage with peers, exchange ideas, and build professional relationships during dedicated networking sessions, panel discussions, and interactive workshops. The event aims to foster a collaborative environment where industry stakeholders can share knowledge and work together to advance the field of pharmaceutical quality control.
Join Us at the 2nd Annual Pharma Impurities Conclave 2024
Whether you are an Analytical R&D professional, QC expert, or researcher in the pharma, the 2nd Annual Pharma Impurities Conclave 2024 is an event you won't want to miss. Join us to stay at the forefront of developments in pharmaceutical impurities, gain valuable insights from industry leaders, and contribute to the ongoing effort to ensure the safety and efficacy of drug products.
For more information and to register, please visit https://www.pharmaimpurities.com/.
We look forward to seeing you there!
Unveiling innovations & anticipating breakthroughs
The challenge of managing and mitigating impurities in drug products remains a critical focus with recent advancements in pharma. Impurities can pose serious health risks to patients and the presence of impurities can affect the safety, efficacy, stability, and the quality of the drugs. To understand the challenges faced by scientists and analytical R&D experts to rid of residual solvents, degradants, or process related impurities, this conclave facilitates knowledge sharing, best practices dissemination, and regulatory updates to ensure practical understanding of those aspects and encourages the highest standards of product quality and patient safety. Ultimately, the 2nd Annual Pharma Impurity Conclave 2024 by Eminence Business Media, scheduled for September 12th – 13th at Hyderabad, serves as a critical platform for the industry professionals to address to those pressing needs for stringent impurity control in drug manufacturing.
Addressing Key Challenges in Pharmaceutical Impurities
Pharmaceutical impurities, whether they arise during the manufacturing process or through degradation over time, can pose significant risks to patient safety. The regulatory landscape governing these impurities is complex and continually evolving. 2nd Annual Pharma Impurities Conclave 2024 aims to provide attendees with the latest insights and practical strategies to navigate these challenges effectively.
A Stellar Line-Up of Expert Speakers
The event will feature a distinguished line-up of speakers from regulatory bodies and leading pharma companies. By bringing together scientists, regulatory experts, and industry leaders, the conclave is to foster collaboration and innovation in impurity analysis, detection, and control strategies.
Key Topics and Sessions
Participants can look forward to a comprehensive agenda that covers a wide range of topics related to pharmaceutical impurities:
Regulatory Updates: Detailed discussions on the latest guidelines from MHRA, FDA, EMA, and ICH, with a focus on permissible impurity levels and compliance requirements.
Analytical Techniques: Sessions on cutting-edge analytical methods for detecting and quantifying impurities, including advancements in mass spectrometry and chromatography.
Risk Assessment and Management: Expert-led discussions on risk assessment frameworks and best practices for managing impurities to ensure patient safety.
Case Studies: Real-world examples of impurity identification, mitigation strategies, and successful regulatory submissions.
Genotoxic Impurities: Special focus on the detection, evaluation, and control of genotoxic impurities, which can pose significant risks even at low levels.Networking and Collaboration Opportunities
The conclave will also provide ample opportunities for networking and collaboration. Attendees can engage with peers, exchange ideas, and build professional relationships during dedicated networking sessions, panel discussions, and interactive workshops. The event aims to foster a collaborative environment where industry stakeholders can share knowledge and work together to advance the field of pharmaceutical quality control.
Join Us at the 2nd Annual Pharma Impurities Conclave 2024
Whether you are an Analytical R&D professional, QC expert, or researcher in the pharma, the 2nd Annual Pharma Impurities Conclave 2024 is an event you won't want to miss. Join us to stay at the forefront of developments in pharmaceutical impurities, gain valuable insights from industry leaders, and contribute to the ongoing effort to ensure the safety and efficacy of drug products.
For more information and to register, please visit https://www.pharmaimpurities.com/.
We look forward to seeing you there!
